Sequence analysis of hepatitis c virus from patients with relapse after a sustained virological response: Relapse or reinfection?

Journal of Infectious Diseases

Volumn 209, Issue 1, 2014, Pages 38-45

  Hara, Koji ^a   Rivera, Maria M ^a   Koh, Christopher ^a   Demino, Mary ^a   Page, Sandra ^a   Nagabhyru, Pothu Raju ^a   Rehermann, Barbara ^a   Liang, T Jake ^a   Hoofnagle, Jay H ^a   Heller, Theo ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Hepatitis C virus; late relapse; liver; sequence

Indexed keywords

ALPHA2B INTERFERON; PEGINTERFERON ALPHA2A; RIBAVIRIN; VIRUS RNA;

5' UNTRANSLATED REGION; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE AMPLIFICATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; MALE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REINFECTION; RELAPSE; RNA ANALYSIS; RNA SEQUENCE; SEQUENCE ANALYSIS; VIRUS DETECTION;

HEPATITIS C VIRUS; LATE RELAPSE; LIVER; SEQUENCE;

ADULT; ANTIVIRAL AGENTS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER; MALE; MIDDLE AGED; PHYLOGENY; RECURRENCE; RNA, VIRAL; SEQUENCE ALIGNMENT;

EID: 84891365395     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit541     Document Type: Article

References (18)

1. Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49:1335-74.
2. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144:705-14.
3. Lauer GM,Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345:41-52.
4. Lindsay KL. Introduction to therapy of hepatitis C. Hepatology 2002; 36:S114-20.
5. Lau DT, Kleiner DE, Ghany MG, Park Y, Schmid P, Hoofnagle JH. 10-Year follow-up after interferon-alpha therapy for chronic hepatitis C. Hepatology 1998; 28:1121-7.
6. Giannini EG, Basso M, Savarino V, Picciotto A. Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients. Aliment Pharmacol Ther 2010; 31:502-8.
7. Ferreira Sda C, Carneiro Mde V, Souza FF, et al. Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferon. Braz J Infect Dis 2010; 14:330-4.
8. Radkowski M, Gallegos-Orozco JF, Jablonska J, et al. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 2005; 41:106-14.
9. Sood A, Midha V, Mehta V, et al. How sustained is sustained viral response in patients with hepatitis C virus infection? Indian J Gastroenterol 2010; 29:112-5.
10. Welker MW, Zeuzem S. Occult hepatitis C: how convincing are the current data? Hepatology 2009; 49:665-75.
11. McHutchison JG DG, Esteban-Mur R, et al. Durability of sustained virologic response in patients with chronic hepatitis C after treatment with interferon alpha-2B alone or in combination with ribavirin. Hepatology 2001; 34 (suppl):244A.
12. Veldt BJ, Saracco G, Boyer N, et al. Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy. Gut 2004; 53:1504-8.
13. Koh C, Heller T, Haynes-Williams V, et al. Long-term outcome of chronic hepatitis C after sustained virological response to interferonbased therapy. Aliment Pharmacol Ther 2013; 37:887-94.
14. Kleiner DE. The liver biopsy in chronic hepatitis C: a view from the other side of the microscope. Semin Liver Dis 2005; 25:52-64.
15. Veerapu NS, Raghuraman S, Liang TJ, Heller T, Rehermann B. Sporadic reappearance of minute amounts of hepatitis C virus RNA after successful therapy stimulates cellular immune responses. Gastroenterology 2011; 140:676-685e1.
16. McHutchison JG, Poynard T, Esteban-Mur R, et al. Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin. Hepatology 2002; 35:688-93.
17. Lee WM, Polson JE, Carney DS, Sahin B, Gale M Jr. Reemergence of hepatitis C virus after 8.5 years in a patient with hypogammaglobulinemia: evidence for an occult viral reservoir. J Infect Dis 2005; 192:1088-92.
18. Takaki A, Wiese M, Maertens G, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 2000; 6:578-82.